Evaluation of the Effect of Fish Oil Alone and in Combination with a Proprietary Chromium Complex on Endothelial Dysfunction, Systemic Inflammation and Lipid Profile in Type 2 Diabetes Mellitus – A Randomized, Double-Blind, Placebo-Controlled Clinical Study

References

• World Health Organization. World Health Statistics. Department of Measurement & Health Information Systems of the Information, Evidence and Research Cluster. Geneva: WHO Press; 2018:7.
   Google Scholar
• Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017. Cardiovasc Diabetol. 2018;17(1):83. doi:10.1186/s12933-018-0728-6
   PubMed Web of Science ®Google Scholar
• Strain WD, Paldánius PM. Diabetes, cardiovascular disease and the microcirculation. Cardiovasc Diabetol. 2018;17(1):57. doi:10.1186/s12933-018-0703-2
   PubMed Web of Science ®Google Scholar
• Stehouwer CD, Lambert J, Donker AJ, van Hinsbergh VW. Endothelial dysfunction and pathogenesis of diabetic angiopathy. Cardiovasc Res. 1997;34(1):55–68. doi:10.1016/S0008-6363(96)00272-6
   PubMedGoogle Scholar
• Pandolfi A, De Filippis EA. Chronic hyperglicemia and nitric oxide bioavailability play a pivotal role in pro-atherogenic vascular modifications. Genes Nutr. 2007;2(2):195–208. doi:10.1007/s12263-007-0050-5
   PubMedGoogle Scholar
• Schofield JD, Liu Y, Balakrishna PR, Malik RA, Soran H. Diabetes dyslipidemia. Diabetes Ther. 2016;7(2):203–219. doi:10.1007/s13300-016-0167-x
   PubMed Web of Science ®Google Scholar
• Kolluru GK, Bir SC, Kevil CG.Endothelial dysfunction and diabetes: effects on angiogenesis, vascular remodeling, and wound healing. Int J Vasc Med.2012;2012:1–30. doi:10.1155/2012/918267
   Google Scholar
• Bretón-Romero R, Feng B, Holbrook M, et al. Endothelial dysfunction in human diabetes is mediated by Wnt5a-JNK signaling. Arterioscler Thromb Vasc Biol. 2016;36(3):561–569. doi:10.1161/ATVBAHA.115.306578
   PubMed Web of Science ®Google Scholar
• Park KH, Park WJ. Endothelial dysfunction: clinical implications in cardiovascular disease and therapeutic approaches. J Korean Med Sci. 2015;30(9):1213–1225. doi:10.3346/jkms.2015.30.9.1213
   PubMed Web of Science ®Google Scholar
• Daiber A, Steven S, Weber A, et al. Targeting vascular (endothelial) dysfunction. Br J Pharmacol. 2017;174(12):1591–1619.
   PubMed Web of Science ®Google Scholar
• Yamazaki D, Hitomi H, Nishiyama A. Hypertension with diabetes mellitus complications. Hypertens Res. 2018;41:147–156. doi:10.1038/s41440-017-0008-y
   PubMed Web of Science ®Google Scholar
• Neaton JD, Blackburn H, Jacobs D, Kuller L, Lee DJ, Sherwin R. Serum cholesterol level and mortality findings for men screened in the multiple risk factor intervention trial. Multiple risk factor intervention trial research group. Arch Intern Med. 1992;152(7):1490–1500.
   PubMedGoogle Scholar
• Aung T, Halsey J, Kromhout D, et al. Associations of omega-3 fatty acid supplement use with cardiovascular disease risks: meta-analysis of 10 trials involving 77917 Individuals. JAMA Cardiol. 2018;3(3):225–233. doi:10.1001/jamacardio.2017.5205
   PubMed Web of Science ®Google Scholar
• Zivkovic AM, Telis N, German JB, Hammock BD. Dietary omega-3 fatty acids aid in the modulation of inflammation and metabolic health. Calif Agric (Berkeley). 2011;65(3):106–111. doi:10.3733/ca.v065n03p106
   PubMed Web of Science ®Google Scholar
• Zhang YF, Gao HF, Hou AJ, Zhou YH. Effect of omega-3 fatty acid supplementation on cancer incidence, non-vascular death and total mortality: a meta-analysis of randomized controlled trials. BMC Public Health. 2014;14:204. doi:10.1186/1471-2458-14-204
   PubMedGoogle Scholar
• Din JN, Sarma J, Harding SA, Lyall K, Newby DE, Flapan AD. Effect of ω-3 fatty acid supplementation on endothelial function, endogenous fibrinolysis and platelet activation in patients with a previous myocardial infarction: a randomised controlled trial. BMJ Open. 2013;3:e003054. doi:10.1136/bmjopen-2013-003054
   PubMedGoogle Scholar
• Chan DC, Watts GF, Barrett PHR, Beilin LJ, Mori TA. Effect of atorvastatin and fish oil on plasma high-sensitivity C-reactive protein concentrations in individuals with visceral obesity. Clin Chem. 2002;48(6):877–883.
   PubMedGoogle Scholar
• Kromhout D, Yasuda S, Geleijnse JM, Shimokawa H. Fish oil and omega-3 fatty acids in cardiovascular disease: do they really work? Eur Heart J. 2012;33(4):436–443. doi:10.1093/eurheartj/ehr362
   PubMed Web of Science ®Google Scholar
• Aucoin M, Cooley K, Knee C, et al. Fish-derived omega-3 fatty acids and prostate cancer: a systematic review. Integr Cancer Ther. 2017;16:32–62. doi:10.1177/1534735416656052
   PubMed Web of Science ®Google Scholar
• Kwak SM, Myung SK, Lee YJ, Seo HG; Korean Meta-analysis Study Group. Efficacy of omega-3 Fatty acid supplements (Eicosapentaenoic acid and Docosahexaenoic acid) in the secondary prevention of cardiovascular disease. Arch Intern Med. 2012;172(9):686–694. doi:10.1001/archinternmed.2012.262
   PubMed Web of Science ®Google Scholar
• Grosso G, Galvano F, Marventano S, et al. Omega-3 fatty acids and depression: scientific evidence and biological mechanisms. Oxid Med Cell Longev. 2014;313570.
   PubMed Web of Science ®Google Scholar
• Weylandt KH, Serini D, Chen YQ, et al. Omega-3 polyunsaturated fatty acids: the way forward in times of mixed evidence. Biomed Res Int. 2015;143109.
   PubMedGoogle Scholar
• Siscovick DS, Barringer TA, Fretts AM, et al. Omega-3 polyunsaturated fatty acid (Fish oil) supplementation and the prevention of clinical cardiovascular disease. A science advisory from the American Heart Association. Circulation. 2017;135(15):e867–84. doi:10.1161/CIR.0000000000000482
   PubMed Web of Science ®Google Scholar
• Nutalapati C, Chiranjeevi UK, Kishan PV, Kiran KK, Pingali U. A randomized, double-blind, placebo-controlled, parallel group clinical study to evaluate the analgesic effect of aqueous extract of terminalia chebula, a proprietary chromium complex, and their combination in subjects with joint discomfort. Asian J Pharm Clin Res. 2016;9(3):264–269.
   Google Scholar
• Hua Y, Clark S, Ren J, Nair S. Molecular mechanisms of chromium in alleviating insulin resistance. J Nutr Biochem. 2012;23(4):313–319. doi:10.1016/j.jnutbio.2011.11.001
   PubMedGoogle Scholar
• Bai J, Xun P, Morris S, Jacobs DR, Liu K, He K. Chromium exposure and incidence of metabolic syndrome among American young adults over a 23-year follow-up: the CARDIA trace element study. Sci Rep. 2015;5:15606. doi:10.1038/srep15606
   PubMed Web of Science ®Google Scholar
• Usharani P, Fatima N, Muralidhar N. Effects of Phyllanthus emblica extract on endothelial dysfunction and biomarkers of oxidative stress in patients with type 2 diabetes mellitus: a randomized, double-blind, controlled study. Diabetes Metab Syndr Obes. 2013;6:275–284. doi:10.2147/DMSO.S46341
   PubMedGoogle Scholar
• Biswas TK, Chakrabarty S, Pandit S, Jana U, Dey SK. Pilot study evaluating the use of Emblica officinalis standardized fruit extract in cardio-respiratory improvement and antioxidant status of volunteers with smoking history. J Herb Med. 2014;4(4):188–194. doi:10.1016/j.hermed.2014.09.002
   Google Scholar
• Khanna S, Das A, Spieldenner J, Rink C, Roy S. Supplementation of a standardized extract from Phyllanthus emblica Improves cardiovascular risk factors and platelet aggregation in overweight/class-1 obese adults. J Med Food. 2015;18(4):415–420. doi:10.1089/jmf.2014.0178
   PubMed Web of Science ®Google Scholar
• Fatima N, Pingali U, Muralidhar N. Study of pharmacodynamic interaction of Phyllanthus emblica extract with clopidogrel and ecosprin in patients with type II diabetes mellitus. Phytomedicine. 2014;21(5):579–585. doi:10.1016/j.phymed.2013.10.024
   PubMed Web of Science ®Google Scholar
• Thirunavukkarasu M, Selvaraju V, Tapias L, Sanchez JA, Palesty JA, Maulik N. Protective effects of Phyllanthus emblica against myocardial ischemia-reperfusion injury: the role of PI3-kinase/glycogen synthase kinase 3β/β-catenin pathway. J Physiol Biochem. 2015;71(4):623–626. doi:10.1007/s13105-015-0426-8
   PubMed Web of Science ®Google Scholar
• Fatima N, Pingali U, Pilli R. Evaluation of Phyllanthus emblica extract on cold pressor induced cardiovascular changes in healthy human subjects. Pharmacognosy Res. 2014;6(1):29–35. doi:10.4103/0974-8490.122914
   PubMedGoogle Scholar
• Usharani P, SudhaRani E, KiranKishore K, Raveendranath P. Evaluation of the effect of a standardized aqueous extract of the fruits of Emblica officinalis on mental stress induced cardiovascular changes in healthy human subjects. IJPSR. 2017;8(10):4138–4146.
   Google Scholar
• Biswas TK, Pandit S, Mondal S, et al. Clinical evaluation of spermatogenic activity of processed Shilajit in oligospermia. Andrologia. 2010;42(1):48–56. doi:10.1111/and.2009.42.issue-1
   PubMedGoogle Scholar
• Pandit S, Biswas S, Jana U, De RK, Mukhopadhyay SC, Biswas TK. Clinical evaluation of purified Shilajit on testosterone levels in healthy volunteers. Andrologia. 2015;xx:1–6.
   Google Scholar
• Das A, Datta S, Rhea B, et al. The human skeletal muscle transcriptome in response to oral shilajit supplementation. J Med Food. 2016;19(7):701–709. doi:10.1089/jmf.2016.0010
   PubMed Web of Science ®Google Scholar
• Niranjan K, Ramakanth GSH, Fatima N, Usharani P. Evaluation of the effect of purified aqueous extract of shilajit in modifying cardiovascular risk with special reference to endothelial dysfunction in patients with type 2 diabetes mellitus. Int J Ayur Pharma Res. 2016;4(4):1–7.
   Google Scholar
• Lawley S, Gupta RC, Goad JT, Canerdy TD, Kalidindi SR. Anti-inflammatory and antiarthritic efficacy and safety of purified shilajit in moderately arthritic dogs. J Vet Sci Anim Husb. 2013;1(3):302.
   Google Scholar
• Das A, El Masry SM, Gnyawali SC, et al. Skin transcriptome of middle-aged women supplemented with natural herbo-mineral shilajit shows induction of microvascular and extracellular matrix mechanisms. J Am Coll Nutr. 2019;38(6):526–536. doi:10.1080/07315724.2018.1564088
   PubMed Web of Science ®Google Scholar
• Joukar S, Najafipour H, Dabiri S, Sheibani M, Sharokhi N. Cardioprotective effect of mumie (shilajit) on experimentally induced myocardial injury. Cardiovasc Toxicol. 2014;14(3):214–221. doi:10.1007/s12012-014-9245-3
   PubMedGoogle Scholar
• Biswas TK, Polley G, Pandit S, et al. Effects of adjunct therapy of a proprietary herbo-chromium supplement in type 2 diabetes: a randomized clinical trial. Int J Diabetes Dev Ctries. 2010;30(3):153–161. doi:10.4103/0973-3930.66512
   Google Scholar
• Peng M, Yang X. Controlling diabetes by chromium complexes: the role of the ligands. J Inorg Biochem. 2015;146:97–103. doi:10.1016/j.jinorgbio.2015.01.002
   PubMed Web of Science ®Google Scholar
• Saiyed ZM, Lugo JP. Impact of chromium dinicocysteinate supplementation on inflammation, oxidative stress, and insulin resistance in type 2 diabetic subjects: an exploratory analysis of a randomized, double-blind, placebo-controlled study. Food Nutr Res. 2016;60:31762. doi:10.3402/fnr.v60.31762
   PubMedGoogle Scholar
• Chowienczyk PJ, Kelly RP, MacCallum H, et al. Photoplethysmographic assessment of pulse wave reflection: blunted response to endothelium-dependent beta2-adrenergic vasodilation in type II diabetes mellitus. J Am Coll Cardiol. 1999;34(7):2007–2014. doi:10.1016/S0735-1097(99)00441-6
   PubMed Web of Science ®Google Scholar
• Naidu MUR, Sridhar Y, Usharani P, Mateen AA. Comparison of two β2 adrenoceptor agonists by different routes of administration to assess human endothelial function. Indian J Pharmacol. 2007;39(3):168–169. doi:10.4103/0253-7613.33439
   Google Scholar
• Millasseau SC, Kelly RP, Ritter JM, Chowienczyk PJ. Determination of age-related increases in large artery stiffness by digital pulse contour analysis. Clin Sci. 2002;103:371–377. doi:10.1042/cs1030371
   PubMed Web of Science ®Google Scholar
• Miranda KM, Espey MG, Wink DA. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide. 2001;5(1):62–71. doi:10.1006/niox.2000.0319
   PubMed Web of Science ®Google Scholar
• Vidyasagar J, Karunakar N, Reddy MS, Rajnarayana K, Surender T, Krishna DR. Oxidative stress and antioxidant status in acute organophosphorous insecticide poisoning. Indian J Pharmacol. 2004;36(2):76–79.
   Google Scholar
• Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959;82(1):70–77. doi:10.1016/0003-9861(59)90090-6
   PubMed Web of Science ®Google Scholar
• Wong CY, Yiu KH, Li SW, et al. Fish-oil supplement has neutral effects on vascular and metabolic function but improves renal function in subjects with Type 2 diabetes mellitus. Diabet Med. 2010;27(1):54–60. doi:10.1111/j.1464-5491.2009.02869.x
   PubMedGoogle Scholar
• Siniarski A, Haberka M, Mostowik M, et al. Treatment with omega-3 polyunsaturated fatty acids does not improve endothelial function in patients with type 2 diabetes and very high cardiovascular risk: a randomized, double-blind, placebo-controlled study (Omega FMD). Atherosclerosis. 2018;271:148–155. doi:10.1016/j.atherosclerosis.2018.02.030
   PubMed Web of Science ®Google Scholar
• Usharani P, Devi CG, Kishore KK, Kumar CU. Effect of proprietary chromium complex and its individual components versus chromium picolinate, chromium polynicotinate and chromium dinicocysteinate on endothelial function, biomarkers and lipid profile in type 2 diabetics - a randomized, double-blind, placebo-controlled study. Int J Pharm Sci Res. 2017;8(5):2267–2276.
   Google Scholar
• Kerksick C, Willoughby D. The antioxidant role of glutathione and N-acetyl-cysteine supplements and exercise-induced oxidative stress. J Int Soc Sports Nutr. 2005;2:38–44. doi:10.1186/1550-2783-2-2-38
   PubMed Web of Science ®Google Scholar
• Shidfar F, Keshavarz A, Hosseyni S, Ameri A, Yarahmadi S. Effects of omega-3 fatty acid supplements on serum lipids, apolipoproteins and malondialdehyde in type 2 diabetes subjects. East Mediterr Health J. 2008;14(2):305–313.
   PubMedGoogle Scholar
• Sorto-Gomez TE, Ortiz GG, Pacheco-Moises FP, et al. Effect of fish oil on glutathione redox system in multiple sclerosis. Am J Neurodegener Dis. 2016;5(2):145–151.
   PubMedGoogle Scholar
• Jin RC, Loscalzo J. Vascular nitric oxide: formation and function. J Blood Med. 2010;1:147–162.
   Google Scholar
• Asemi Z, Soleimani A, Shakeri H, Mazroii N, Esmaillzadeh A. Effects of omega-3 fatty acid plus alpha-tocopherol supplementation on malnutrition-inflammation score, biomarkers of inflammation and oxidative stress in chronic hemodialysis subjects. Int Urol Nephrol. 2016;48(11):1887–1895. doi:10.1007/s11255-016-1399-4
   PubMedGoogle Scholar
• Yamada H, Yoshida M, Nakano Y, et al. In vivo and in vitro inhibition of monocyte adhesion to endothelial cells and endothelial adhesion molecules by eicosapentaenoic acid. Arterioscler Thromb Vasc Biol. 2008;28(12):2173–2179. doi:10.1161/ATVBAHA.108.171736
   PubMed Web of Science ®Google Scholar
• Hocaoglu-Emre FS, Saribal D, Yenmis G, Guvenen G. Vascular cell adhesion molecule 1, intercellular adhesion molecule 1, and cluster of differentiation 146 levels in patients with Type 2 diabetes with complications. Endocrinol Metab (Seoul). 2017;32(1):99–105. doi:10.3803/EnM.2017.32.1.99
   PubMedGoogle Scholar
• Calder PC. Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? Br J Clin Pharmacol. 2013;75(3):645–662. doi:10.1111/j.1365-2125.2012.04374.x
   PubMed Web of Science ®Google Scholar
• Kamath DY, Xavier D, Sigamani A, Pais P. High sensitivity C-reactive protein (hsCRP) & cardiovascular disease: an Indian perspective. Indian J Med Res. 2015;142(3):261–268. doi:10.4103/0971-5916.166582
   PubMedGoogle Scholar
• Schiano V, Laurenzano E, Brevetti G, et al. Omega-3 polyunsaturated fatty acid in peripheral arterial disease: effect on lipid pattern, disease severity, inflammation profile, and endothelial function. Clin Nutr. 2008;27(2):241–247. doi:10.1016/j.clnu.2007.11.007
   PubMed Web of Science ®Google Scholar
• Mackay I, Ford I, Thies F, Fielding S, Bachoo P, Brittenden J. Effect of Omega-3 fatty acid supplementation on markers of platelet and endothelial function in subjects with peripheral arterial disease. Atherosclerosis. 2012;221(2):514–520. doi:10.1016/j.atherosclerosis.2011.12.041
   PubMedGoogle Scholar
• Usharani P, Kishan PV, Fatima N, Kumar UC. A comparative study to evaluate the effect of highly standardised aqueous extracts of Phyllanthus emblica, withania somnifera and their combination on endothelial dysfunction and biomarkers in subjects with type II diabetes mellitus. IJPSR. 2014;5(7):2687–2697.
   Google Scholar
• Harris WS, Ginsberg HN, Arunakul N, et al. Safety and efficacy of Omacor in severe hypertriglyceridemia. J Cardiovasc Risk. 1997;4(5–6):385–391. doi:10.1097/00043798-199710000-00011
   PubMedGoogle Scholar
• Koski RR. Omega-3-acid Ethyl Esters (Lovaza) For severe hypertriglyceridemia. Pharm Ther. 2008;33(5):271–303.
   Google Scholar
• Bays HE, Ballantyne CM, Kastelein JJ, Isaacsohn JL, Braeckman RA, Soni PN. Eicosapentaenoic acid ethyl ester (AMR101) therapy in patients with very high triglyceride levels (from the Multi-center, plAcebo-controlled, Randomized, double-blINd, 12-week study with an open-label Extension [MARINE] trial). Am J Cardiol. 2011;108(5):682–690. doi:10.1016/j.amjcard.2011.04.015
   PubMed Web of Science ®Google Scholar
• Kataoka Y, Uno K, Puri R, Nicholls SJ. Epanova(®) and hypertriglyceridemia: pharmacological mechanisms and clinical efficacy. Future Cardiol. 2013;9(2):177–186. doi:10.2217/fca.13.4
   PubMedGoogle Scholar
• Cicero AF, Rosticci M, Morbini M, et al. Lipid-lowering and anti-inflammatory effects of omega 3 ethyl esters and krill oil: a randomized, cross-over, clinical trial. Arch Med Sci. 2016;12(3):507–512. doi:10.5114/aoms.2016.59923
   PubMedGoogle Scholar
• Sawada T, Tsubata H, Hashimoto N, et al. Effects of 6-month eicosapentaenoic acid treatment on postprandial hyperglycemia, hyperlipidemia, insulin secretion ability, and concomitant endothelial dysfunction among newly - diagnosed impaired glucose metabolism subjects with coronary artery disease. An open label, single blinded, prospective randomized controlled trial. Cardiovasc Diabetol. 2016;15(1):121.
   PubMedGoogle Scholar
• Brown TJ, Brainard J, Song F, et al. Omega-3, omega-6, and total dietary polyunsaturated fat for prevention and treatment of type 2 diabetes mellitus: systematic review and meta-analysis of randomised controlled trials. BMJ. 2019;366:l4697. doi:10.1136/bmj.l4697
   PubMedGoogle Scholar